Efficacy of Using Large Language Model to Assist in Diabetic Retinopathy Detection
1 other identifier
interventional
535
1 country
1
Brief Summary
With the increase in population and the rising prevalence of various diseases, the workload of disease diagnosis has sharply increased. The accessibility of healthcare services and long waiting times have become common issues in the public health medical system, with many primary patients having to wait for extended periods to receive medical services. There is an urgent need for rapid, accurate, and low-cost diagnostic services.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2022
CompletedFirst Posted
Study publicly available on registry
February 9, 2022
CompletedStudy Start
First participant enrolled
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2023
CompletedJanuary 19, 2024
January 1, 2024
3 months
January 29, 2022
January 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
AUROC of the self-evaluation tool
The performance of the self-evaluation tool is evaluated with accuracy with reference to the diagnostic labels by senior ophthalmologists based on fundus photos.
Immediately after using the chatbot
Study Arms (1)
A self-evlaution tool based on Large Language Model
EXPERIMENTALThe self-evlaution tool, powered by a large language model, processes user queries through a comprehensive generation, decision, action, and safety framework to deliver optimal responses. The system's key features include retrieval-augmented in-context learning, which enhances the responses generated by sourcing information from reliable websites. It also incorporates a Guardrail module to mitigate potential harmful content in the responses by validating the content before delivery. Additionally, the system features a Self-checking memory module that maintains essential clinical characteristics across multi-turn dialogues, ensuring consistent and continuous interactions with users.
Interventions
Following the baseline assessment, participants will be guided to use a self-evaluation tool independently to assess their risk of diabetic retinopathy (DR). This tool is a fusion of a conversational AI system based on LLM and an existing logistic diagnostic model. The AI system is designed to collect clinical variables, including age, duration of diabetes, Body Mass Index (BMI), and insulin usage. Additionally, clinical test data such as mean arterial pressure, HbA1c, serum creatinine, and microalbuminuria will be extracted from a local dataset using the patient's name and ID. Once collected, these data will be transmitted to a server-based diagnostic model for further analysis to determine the presence of DR.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhognshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, 510000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yingfeng Zheng
Zhongshan Ophthalmic Center, Sun Yat-sen University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 29, 2022
First Posted
February 9, 2022
Study Start
May 1, 2023
Primary Completion
July 30, 2023
Study Completion
July 30, 2023
Last Updated
January 19, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share